Cargando…
High Expression of PKM2 Was Associated with the Poor Prognosis of Acute Leukemia
PURPOSE: To explore the clinical significance of plasma pyruvate kinase M2 (PKM2) in assessing the incidence and prognosis of acute leukemia. METHODS: Plasma samples from 56 acute myeloid leukemia (AML) patients, 40 acute lymphoblastic leukemia (ALL) patients, and 66 plasma samples from healthy indi...
Autores principales: | Huang, Yunxiu, Chen, Lin-mu, Xie, Jin-ye, Han, Hui, Zhu, Bao-fang, Wang, Luo-jia, Wang, Wei-jia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8520821/ https://www.ncbi.nlm.nih.gov/pubmed/34675679 http://dx.doi.org/10.2147/CMAR.S331076 |
Ejemplares similares
-
PKM2 regulates neural invasion of and predicts poor prognosis for human hilar cholangiocarcinoma
por: Yu, Guanzhen, et al.
Publicado: (2015) -
Expression level and prognostic potential of beta-catenin–interacting protein in acute myeloid leukemia
por: Han, Hui, et al.
Publicado: (2022) -
High Expression of VAV Gene Family Predicts Poor Prognosis of Acute
Myeloid Leukemia
por: Mu, Dan, et al.
Publicado: (2021) -
PKM2 promotes metastasis by recruiting myeloid-derived suppressor cells and indicates poor prognosis for hepatocellular carcinoma
por: Liu, Wei-Ren, et al.
Publicado: (2014) -
Pyruvate kinase M2 (PKM2) expression correlates with prognosis in solid cancers: a meta-analysis
por: Zhu, Haiyan, et al.
Publicado: (2016)